Daunorubicin and blood bilirubin increased 
Daunorubicin and blood bilirubin increased Patient Reports February 11, 2012
Daunorubicin Side Effects Report #4578502-7
Daunorubicin side effect was reported by a Health Professional from on Feb 04, 2005. Male patient, weighting 139.0 lb, was diagnosed with erythroleukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood bilirubin increased, deep vein thrombosis
, febrile neutropenia, pleural effusion, staphylococcal sepsis. Daunorubicin dosage: 45 MG/M2 QD D 1-3 INTRAVENOU. During the same period patient was treated with CYTARABINE. Patient recovered.Daunorubicin Side Effects Report #4578607-0
Daunorubicin side effect was reported by a Consumer or non-health professional from on Feb 08, 2005. Female patient, 73 years of age, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood bilirubin increased, cough, febrile neutropenia, sinus tachycardia. Daunorubicin dosage: 45 MG/M2 OTHER. During the same period patient was treated with CYTARABINE, CIPROFLOXACIN, SYNTHROID, CALTRATE PLUS, GLUCOSAMINE, ACTONEL. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #4696747-2
Daunorubicin side effect was reported by a Pharmacist from on Apr 21, 2005. Male patient, 31 years of age, was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased. Daunorubicin dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.
Daunorubicin Side Effects Report #4648600-8
Daunorubicin side effect was reported by a Pharmacist from on Apr 21, 2005. Male patient was diagnosed with acute myeloid leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood bilirubin increased. Daunorubicin dosage: unknown. Patient recovered.
Daunorubicin Side Effects Report #4670398-8
Daunorubicin side effect was reported by a Consumer or non-health professional from on May 11, 2005. Female patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood bilirubin unconjugated increased, blood cholinesterase decreased, blood fibrinogen decreased, cholestasis. Daunorubicin dosage: 45 MG/M2. During the same period patient was treated with VINCRISTINE, CYLOPHOSPHAMIDE, ASPARAGINASE, PREDNISOLONE. Patient recovered.
Daunorubicin Side Effects Report #4680263-8
Daunorubicin side effect was reported by a Consumer or non-health professional from on May 11, 2005. Female patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase decreased, blood fibrinogen decreased, gamma-glutamyltransferase increased. Daunorubicin dosage: 45 MG/M2. During the same period patient was treated with VINCRISTINE, CYCLOPHOSPHAMIDE, ASPARAGINASE, PREDNISOLONE. Patient recovered.
Daunorubicin Side Effects Report #4773149-1
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 15, 2005. Male patient, weighting 171.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, cholelithiasis, computerised tomogram abnormal, ejection fraction decreased, hemiparesis, hepatosplenic candidiasis, lung consolidation, lung infection. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #4799935-X
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation
, blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #4799942-7
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation
, blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #4799946-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2005. Female patient, weighting 169.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alpha haemolytic streptococcal infection, atrial fibrillation
, blood bilirubin increased, blood fibrinogen increased, blood phosphorus increased, body temperature increased, brain natriuretic peptide increased, constipation . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #4801407-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 11, 2005. Male patient, weighting 171.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: atelectasis, blood alkaline phosphatase increased, blood bilirubin increased, chest pain
, cholelithiasis, computerised tomogram abnormal, ejection fraction decreased, hemiparesis, hepatosplenic candidiasis. Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #4815451-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 27, 2005. Male patient, weighting 171.1 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: asthenia, atelectasis, blood bilirubin increased, chest pain
, cholelithiasis, computerised tomogram abnormal, ejection fraction decreased, hepatosplenic candidiasis, infection . Daunorubicin dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #5092190-5
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2006. Male patient, weighting 202.1 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood bilirubin increased. Daunorubicin dosage: 424 MG. During the same period patient was treated with PREDNISONE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5195925-6
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2006. Female patient, weighting 138.0 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: arthralgia, bacteroides infection, blood bilirubin increased, blood culture positive, body temperature increased, culture tissue specimen positive, erythema, hypotension. Daunorubicin dosage: 83.5 MG. During the same period patient was treated with DEXAMETHASONE, CYTARABINE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5385279-4
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Female patient, weighting 60.85 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal pain
, blood bilirubin increased, jaundice . Daunorubicin dosage: 87 MG. During the same period patient was treated with METHOTREXATE, PREDNISONE, VINCRISTINE SULPHATE, CYTARABINE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #5390181-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, weighting 183.0 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, alanine aminotransferase increased, aspartate aminotransferase increased, aspergillosis, blood bilirubin increased, febrile neutropenia, fungaemia, hepatic function abnormal, hepatic steatosis. Daunorubicin dosage: 4 MG. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Daunorubicin Side Effects Report #5392036-1
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2007. Female patient, weighting 60.85 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: blood bilirubin increased, jaundice
. Daunorubicin dosage: 87 MG. During the same period patient was treated with VINCRISTINE SULPHATE, PREDNISONE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #5400118-0
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on July 27, 2007. Female patient, weighting 183.0 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, acute lymphocytic leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, computerised tomogram abnormal, fungaemia, fungal infection
, hepatic function abnormal. Daunorubicin dosage: 4 MG. During the same period patient was treated with DEXAMETHASONE, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #5636218-X
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2008. Female patient, weighting 233.7 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, blood ph decreased, neutropenia, pco2 increased, pneumonia
, po2 increased, refusal of treatment by relative, renal failure acute. Daunorubicin dosage: 95 MG. During the same period patient was treated with ELSPAR, VINCRISTINE SULPHATE, AZITHROMYCIN, CEFEPIME, FILGRASTIM, HUMULIN, MAGNESIUM SULPHATE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.Daunorubicin Side Effects Report #5898031-8
Daunorubicin side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2008. Female patient, weighting 9.99 lb, was treated with Daunorubicin. After drug was administered, patient experienced the following side effects: abdominal distension, alanine aminotransferase increased, ascites, blood bilirubin increased, hepatomegaly, hepatotoxicity, venoocclusive liver disease. Daunorubicin dosage: 14MG. During the same period patient was treated with METHOTREXATE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, CYTARABINE, ACTIGALL, CIPROFLOXACIN, DAPSONE. Patient recovered.